Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$101K Sell
1,497
-5,943
-80% -$400K ﹤0.01% 192
2025
Q1
$580K Buy
+7,440
New +$596K 0.02% 148
2024
Q3
Sell
-1,641
Closed -$120K 204
2024
Q2
$120K Sell
1,641
-41,272
-96% -$2.97M ﹤0.01% 164
2024
Q1
$3.74M Buy
42,913
+7,181
+20% +$543K 0.14% 96
2023
Q4
$2.74M Sell
35,732
-19,217
-35% -$1.29M 0.1% 104
2023
Q3
$3.89M Buy
54,949
+22,650
+70% +$1.85M 0.17% 93
2023
Q2
$2.7M Buy
+32,299
New +$2.36M 0.12% 101
2021
Q3
Sell
-14,500
Closed -$1.87M 278
2021
Q2
$1.87M Buy
14,500
+9,821
+210% +$1.21M 0.18% 126
2021
Q1
$621K Buy
+4,679
New +$570K 0.06% 225
2020
Q1
Sell
-2,402
Closed -$210K 372
2019
Q4
$210K Sell
2,402
-8,266
-77% -$778K 0.02% 401
2019
Q3
$929K Buy
10,668
+3,883
+57% +$333K 0.05% 377
2019
Q2
$590K Hold
6,785
0.05% 368
2019
Q1
$432K Sell
6,785
-12,904
-66% -$795K 0.04% 430
2018
Q4
$1.25M Buy
19,689
+2,866
+17% +$189K 0.15% 175
2018
Q3
$1.24M Buy
+16,823
New +$1.28M 0.07% 300
2018
Q1
Sell
-49,301
Closed -$3.21M 455
2017
Q4
$3.21M Buy
+49,301
New +$3.52M 0.12% 209

Other funds holding KMX

Meag Munich Ergo's KMX Position: Q2 2025 in Review

Meag Munich Ergo reduced its CarMax (KMX) stake by 80% in Q2 2025, selling an estimated $400K and leaving 1,497 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #192.

Meag Munich Ergo first reported a position in KMX in Q4 2017 and has held it in 16 quarters since. The position peaked at $3.89M in Q3 2023. 731 funds tracked by Wall St. Rank hold KMX as of Q2 2025.

  • Meag Munich Ergo held 1,497 shares of CarMax worth $101K as of Q2 2025.
  • Meag Munich Ergo sold 5,943 CarMax shares in Q2 2025, an estimated $400K.
  • CarMax made up ﹤0.01% of Meag Munich Ergo's portfolio in Q2 2025, its #192 holding.
  • Meag Munich Ergo first reported a position in CarMax in Q4 2017 and has held it in 16 quarters since.
  • Meag Munich Ergo's CarMax position peaked at $3.89M in Q3 2023.
  • 731 funds tracked by Wall St. Rank held CarMax as of Q2 2025.

Based on Meag Munich Ergo's 13F filing for Q2 2025, filed 16 Jul 2025.